Studies show the drug pricing in the Inflation Reduction Act will hurt drug research and development. Some want to take federal regulation even further
Utah’s life sciences industry has been the fastest growing in the nation for the past decade and a key sector of the state’s economy. To keep this innovation engine humming, we need to sound the alarm about proposals in Washington, D.C., that would hamper the development of new treatments for patients in our state and across the nation...